Skip to content

Management of Mandal Kushtha (PSORIASIS) through Panchkarma

A comparative clinical study of Sarvanga Takradhara and Kushthaghana mahakashaya parisheka after Virechana karma in the management of Mandal Kushtha with special reference to Plaque Psoriasis. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065851
Enrollment
30
Registered
2024-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere Health Condition 2: L408- Other psoriasis

Interventions

None listed

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients between 18 to 60 years of age. 2.Patients with the classical features of Mandal Kushtha (Plaque Psoriasis). 3.Patients not taking any other medicine for Mandal Kushtha (Plaque Psoriasis). 4.Patients fit for Virechana Karma. 5.Patients willing to sign consent form for trial.

Exclusion criteria

Exclusion criteria: 1.Pregnant women and lactating mothers. 2.Patients suffering from systemic disorders as Cardiac Problem, Uncontrolled Diabetes mellitus, Uncontrolled Hypertension, Paralysis, Malignancy, HIV, HBsAg, Leprosy. 3.Patients suffering from Psoriatic Arthritis. 4.Patients unfit for Virechana Karma.

Design outcomes

Primary

MeasureTime frame
Changes in PASI Score at Baseline (Day 0), Day 15, Day 30.Timepoint: four weeks

Secondary

MeasureTime frame
Changes in ayurvedic parameters at Day 0, Day 15, Day 30.Timepoint: 4 weeks

Countries

India

Contacts

Public ContactDr Gopesh Mangal

National Institute of Ayurveda Jaipur

gmangal108@gmail.com8619849011

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026